COPD patients | n | \( \overline{\mathrm{X}} \)±SD |
---|---|---|
Age (years) | 66 | 70 ± 8 |
Sex (male %) | 66 | 52(82) |
Tobacco (pack-year) | 66 | 41 ± 11 |
Anthropometry | ||
Weight (kg) | 66 | 71 ± 18 |
BMI (kg/m2) | 66 | 26.2 ± 6.5 |
FFMI (kg/m2) | 52 | 16.9 ± 2.7 |
Exacerbations (n) | 66 | 1.3 ± 1.2 |
Blood test and flow cytometry | ||
Eosinophils (total/mm3) | 66 | 199 ± 164 |
HCMV+ (%) | 35 | 31(89) |
NK | 59 | 19.1 ± 10 |
NKG2C+ | 63 | 14.4 ± 17 |
NKG2A+ | 46 | 29.2 ± 17 |
Functional testing | ||
FEV1 (% pred.) pre/post bd | 66 | 37 ± 14/39 ± 15 |
FEV1/FVC (%) pre/post bd | 66 | 44 ± 11/44 ± 12 |
RV/TLC (%) | 60 | 63 ± 11 |
DLco (% pred.) | 60 | 44 ± 20 |
Kco (% pred.) | 60 | 51 ± 20 |
SpO2 (%) | 66 | 93 ± 3 |
6MWT (m) | 56 | 359 ± 122 |
CT Scan | ||
Emphysema (%) | 58 | 44(76) |
Bronchiectasis (%) | 58 | 13(22) |